NCT05018325

Brief Summary

The investigators' null hypothesis is that a withdrawal time of 9 to 10 minutes is non-inferior to a withdrawal time of 12 minutes or greater. Thus, the goal of this tandem design trial is to compare the additional diagnostic yield (# of missed lesions) for withdrawal times exceeding 10 minutes for screening/surveillance colonoscopies. Although withdrawal times longer than the standard 6-minute recommendation have been shown to be beneficial, there is limited prospective evidence investigating the benefit or lack thereof for withdrawal times greater than 9-10 minutes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

August 30, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2022

Completed
Last Updated

August 31, 2022

Status Verified

August 1, 2022

Enrollment Period

12 months

First QC Date

August 12, 2021

Last Update Submit

August 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Miss rate of polyps

    * Miss rate = missed polyps/missed polyps + polyps found during 1st exam * Polyps is defined as adenomas and sessile serrated adenomas (SSA)

    Time of colonoscopy (day 1)

Secondary Outcomes (1)

  • Miss rate of advanced adenomas

    Time of colonoscopy (day 1)

Study Arms (3)

Arm 1: Colonoscopy 6 minute withdrawal time

ACTIVE COMPARATOR

-Undergo colonoscopy with the standard 6-minute withdrawal time followed by a tandem colonoscopy of at least another 6-minute withdrawal time.

Procedure: Colonoscopy with 6 minute withdrawal

Arm 2: Colonoscopy 9 minute withdrawal time

EXPERIMENTAL

-Undergo a 9-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time.

Procedure: Colonoscopy 9 minute withdrawal

Arm 3: Colonoscopy 12 minute withdrawal time

EXPERIMENTAL

-Undergo colonoscopy with a 12-minute withdrawal time followed by a tandem colonoscopy with at least the standard 6-minute withdrawal time

Procedure: Colonoscopy 12 minute withdrawal

Interventions

Withdrawal time will be determined using a digital stopwatch by the nursing staff.

Arm 1: Colonoscopy 6 minute withdrawal time

Withdrawal time will be determined using a digital stopwatch by the nursing staff.

Arm 2: Colonoscopy 9 minute withdrawal time

Withdrawal time will be determined using a digital stopwatch by the nursing staff.

Arm 3: Colonoscopy 12 minute withdrawal time

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be between the ages of 18 and 75 years
  • Must be a patient undergoing screening or surveillance colonoscopy
  • Must be able to understand and willing to sign an IRB-approved written informed consent document.

You may not qualify if:

  • Inability to provide informed consent.
  • Personal history of colorectal cancer (CRC)
  • Personal history of colon surgery or colon resection
  • Personal history of Inflammatory bowel disease
  • Personal history of familial polyposis
  • Current pregnancy
  • Active GI bleeding
  • Colonoscopy exams where the cecum cannot be reached (randomization will occur after cecum is reached).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

MeSH Terms

Conditions

Colonic NeoplasmsRectal NeoplasmsColorectal Neoplasms

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Vladimir Kushnir, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2021

First Posted

August 24, 2021

Study Start

August 30, 2021

Primary Completion

August 19, 2022

Study Completion

August 19, 2022

Last Updated

August 31, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

Individual participant data that underline the results reported, after deidentification.

Shared Documents
STUDY PROTOCOL
Time Frame
Immediately following publication without an end date
Access Criteria
Anyone who wishes to access the data.

Locations